In a major milestone for biomedical science, researchers led by the Agency for Science, Technology and Research’s Genome Institute of Singapore (A*STAR GIS) have unveiled one of the world’s largest and most...

When a blacklegged tick (Ixodes scapularis) bites into human skin, it does more than simply take a blood meal. Through its saliva, the tick injects a complex cocktail of proteins designed to suppress the...

A groundbreaking study led by the Perelman School of Medicine at the University of Pennsylvania reveals that unvaccinated children and adolescents were up to 20 times more likely to develop long COVID than...

More than three years of intense negotiations, marked by missed deadlines, high stakes disagreements, and political walkouts, have finally led to a historic agreement between 194 World Health Organization...

A recent surge in infections across Latin America has propelled the Oropouche virus, an arbovirus long considered a marginal health threat, into the global spotlight. Like dengue and Zika, Oropouche virus...

A groundbreaking nationwide study from France has sounded a sobering alarm about the long-term health consequences faced by individuals hospitalized with COVID-19, underscoring the pandemic’s enduring...

Antibiotic resistance is rapidly becoming one of the gravest threats to global health. With projections suggesting that drug-resistant infections could surpass cancer as a leading cause of death within the...

A groundbreaking study led by Stanford Medicine has unveiled a compelling link between the shingles vaccine and a reduced risk of dementia in older adults. Analyzing health records from over 280,000...

In a significant step forward for global health security, researchers at Washington State University (WSU) have developed a cutting-edge artificial intelligence (AI) model capable of identifying animal species...

The University of Oxford in partnership with the Coler Lab at Seattle Children’s Research Institute (SCRI) has begun a new clinical trial called TB045, which aims to test tuberculosis (TB) vaccine safety and...

Amid rising vaccine misinformation, declining public confidence in science, and new outbreaks of preventable diseases, a coalition of 34 leading scientific and medical organizations—spearheaded by the American...

New research from the Perelman School of Medicine at the University of Pennsylvania suggests that prior exposure to specific seasonal influenza strains provides older adults with some immunity against H5N1...

Cornell researchers have developed a new vaccine platform that could provide more robust, longer-lasting protection from both COVID-19 and influenza, and broader immunity to different flu strains. In a study...

Respiratory syncytial virus (RSV) poses a significant health risk to individuals aged 60 years and older, often leading to severe acute respiratory infections (ARIs) that result in hospitalizations and...

Working toward more effective tuberculosis (TB) vaccines, researchers at Weill Cornell Medicine have developed two strains of mycobacteria with “kill switches” that can be triggered to stop the...

The effectiveness of vaccines plays a crucial role in public health, determining their ability to prevent infection, reduce disease severity, and limit transmission within communities. A recent study examined...

Bats are known to harbor more zoonotic viruses than any other mammalian order, yet they rarely suffer from severe disease symptoms. This paradox has intrigued scientists for years, particularly given...

This study aimed to estimate the incidence of symptomatic Borrelia burgdorferi sensu lato (Bbsl) infections in nine European countries by adjusting public health Lyme borreliosis (LB) surveillance data for...

As the COVID-19 pandemic continues to transition toward endemicity, the global community faces the complex challenge of adapting booster vaccination strategies to meet diverse needs. While some countries, like...

An international project into flu immunity could help develop better medications and vaccines to prevent severe disease. Imperial researchers will investigate how people develop resistance to the flu in an...

Scientists at Harvard Medical School and Boston University Chobanian & Avedisian School of Medicine have mapped a critical component of the Nipah virus, a highly lethal bat-borne pathogen that has caused...

Researchers have identified strategies to make COVID-19 vaccine information more accessible and understandable for diverse audiences. Their work, published in Vaccine, focused on enhancing a tool known as the...

The World Health Organization (WHO) announced a suspected outbreak of the Marburg virus in Tanzania’s Kagera region. This area, which has previously faced a similar outbreak, is now grappling with nine...

The COVID-19 pandemic laid bare the weaknesses of a centralized vaccine manufacturing model, exposing its inability to meet the demands of an interconnected yet inequitable world. As countries struggled with...

T cells can independently prevent viral infections, challenging the dominance of antibodies in vaccine design. Future vaccines should aim to stimulate both T-cell and antibody responses for broader protection...

A new and mysterious virus, transmitted by ticks, has emerged in northeastern China, raising concerns among scientists and public health experts alike. Known as the Xue-Cheng virus (XCV), this discovery marks...

Ten years ago, Sierra Leone, Liberia, and Guinea faced a devastating Ebola epidemic that claimed over 11,000 lives and gripped the world in fear. The 2014 outbreak was the largest since Ebola’s discovery in...

Respiratory syncytial virus (RSV) cases have reached alarming levels across the United States, with several states reporting “very high” activity according to CDC wastewater testing. This surge...

In a recent opinion article published in PLOS Global Public Health, pediatrician-scientist Prof. Peter Hotez of Baylor College of Medicine highlights urgent measures needed to combat the growing momentum of...

A recent article in Molecular Biomedicine by researchers from the Datta Meghe Institute of Higher Education and Research examines the pivotal role of Artificial Intelligence (AI) in pandemic preparedness and...

While the highly pathogenic H5N1 avian influenza virus (HPAI H5N1) poses a low risk to the general public, U.S. public health experts emphasize the importance of ongoing monitoring and preparedness. Available...

Researchers have developed a groundbreaking method to rapidly identify infectious and vaccine-resistant variants of viruses and bacteria, including those causing influenza, COVID-19, whooping cough, and...

Eighty-Seventh Edition of the Global Health Cast presented by Prof. Schmitt and Dr. Sanicas.

Download PDF here

Penn researchers unveil groundbreaking mRNA avian flu vaccine In a significant stride toward pandemic preparedness, researchers at the Perelman School of Medicine at the University of Pennsylvania have...

Eighty-Sixth Edition of the Global Health Cast presented by Prof. Schmitt and Dr. Sanicas.

Download PDF here

Zoonotic pathogens, disease-causing agents transmitted from animals to humans, pose a critical and often overlooked threat to public health, particularly through the food chain. The recent COVID-19 pandemic...

A single modification in the protein found on the surface of the highly pathogenic avian influenza (HPAI) H5N1 influenza virus currently circulating in U.S. dairy cows could allow for easier transmission among...

This year saw record-breaking surges in dengue and mpox cases, a polio outbreak in Gaza, and the emergence of new viral threats. Dengue cases reached unprecedented levels Dengue fever, a mosquito-borne...

Australia’s pioneering mRNA COVID-19 vaccine has shown promising results in overcoming immune imprinting, a challenge that limits immune responses to new virus variants. The findings, published in Molecular...

Eighty-Fifth Edition of the Global Health Cast presented by Prof. Schmitt and Dr. Sanicas.

Download PDF here

Understanding how quickly viruses spread is crucial for preventing and controlling disease outbreaks. In a groundbreaking study published in PLOS Biology on December 3rd, researchers led by Simon Dellicour...

Eighty-Fourth Edition of the Global Health Cast presented by Prof. Schmitt and Dr. Sanicas.

Download PDF here

A one-size-fits-all approach for scheduling COVID-19 booster shots may not be the most effective, according to a new study by researchers at the Yale School of Public Health (YSPH) and University of North...

We live in an increasingly connected and social world, where infectious diseases are deeply intertwined with human interactions and the flow of information. As a result, controlling outbreaks requires more...

With 46% of global prophylactic vaccine trials and 31% of therapeutic trials conducted in the Asia-Pacific region, the region has emerged as a global leader in vaccine research and development. A collaborative...

Researchers at Columbia University Vagelos College of Physicians and Surgeons have uncovered how COVID-19 mRNA vaccines bolster the immune system by generating memory T and B cells, critical for long-term...

In a sobering development for public health in Canada, a British Columbia teenager is in critical condition after contracting what is believed to be the country’s first human case of bird flu. The case...

The World Health Organization (WHO) released a groundbreaking study identifying 17 priority pathogens for vaccine development. This initiative represents the first global effort to systematically evaluate...

The development of mRNA technology marks one of the most groundbreaking moments in modern medicine. Once relegated to experimental laboratories, it emerged as a beacon of hope during the COVID-19 pandemic...

There is no cure for the common cold. But there are cures — or at least vaccines — for other viruses, and researchers are working hard to build a toolbox to be able to rapidly develop vaccines for new and...

The development of mRNA technology marks one of the most groundbreaking moments in modern medicine. Once relegated to experimental laboratories, it emerged as a beacon of hope during the COVID-19 pandemic...

A new variant of human mpox has claimed the lives of approximately 5% of people with reported infections in the Democratic Republic of the Congo since 2023, many of them children. Since then, it has spread to...

Researchers at the Uniformed Services University (USU) have developed a killed, whole-cell vaccine that demonstrates high efficacy against chlamydia infections. This groundbreaking work, led by Drs. George...

The latest omicron subvariants carry specific mutations that may allow the SARS-CoV-2 virus to be better at evading immune protection Over the last year, a whole different family of COVID-19 variants has...

Imperial College London hosted the Natural Sciences Research Showcase on 26 September that spotlighted cutting-edge research by the Faculty of Natural Science’s early-career scientists. Bringing the event to a...

Researchers from the Medical Universities of Vienna and Innsbruck have discovered that SARS-CoV-2 exploits three key host proteins that typically suppress the activity of the complement system—a crucial...

Eighty-Third Edition of the Global Health Cast presented by Prof. Schmitt and Dr. Sanicas.

Download PDF here 

Eighty-Second Edition of the Global Health Cast presented by Prof. Schmitt and Dr. Sanicas.

Download PDF here

Scientists investigating animal viruses with potential to infect humans have identified a critical protein that could enable spillover of a family of organisms called arteriviruses. In a new study, researchers...

The Democratic Republic of the Congo (DRC) has reached a major public health milestone by successfully integrating the malaria vaccine into its national routine immunization programme. This remarkable...

Investigators led by Pablo Penaloza-MacMaster, PhD, associate professor of Microbiology-Immunology, have discovered that administering an antibody treatment four days after mRNA vaccination enhances immune...

Scientists at the Icahn School of Medicine at Mount Sinai have developed a novel antibody platform called the Adaptive Multi-Epitope Targeting and Avidity-Enhanced (AMETA) Nanobody Platform, designed to...

During the COVID pandemic, many of us have received multiple mRNA vaccines. New work by researchers at the VIB-UGent Center for Inflammation Research, Ghent University, and University Hospital Ghent, among...

Imagine living in a world where a simple infection could be life-threatening because no antibiotics work. This is the looming threat of antimicrobial resistance (AMR), and it’s a reality that many young people...

Scientists at Delft University of Technology have discovered that our immune system uses Guanylate Binding Proteins (GBPs) to fight off bacterial infections by forming a destructive coat around bacteria. This...

A new mRNA-based vaccine offers significant promise in both treating and preventing the highly contagious and notoriously difficult-to-treat Clostridioides difficile (C. difficile) infection, also known as C...

The value of mRNA licensing agreements has skyrocketed by a staggering 800% between 2019 and 2024, driven by the success of mRNA-based COVID-19 vaccines and growing confidence in the technology’s broader...

 
Eighty-first Edition of the Global Health Cast presented by Prof. Schmitt and Dr. Sanicas.

 
Download PDF here

Eightieth Edition of the Global Health Cast presented by Prof. Schmitt and Dr. Sanicas.

Download PDF here

Presented by Dr. January Anne Pardo, and Prof. Edsel Maurice Salvana, MD In collaboration with Visit us at & for more information Dr. Edsel Maurice Salvana is a professor of medicine and Infectious...

The U.S. is currently grappling with another outbreak of West Nile virus (WNV), a mosquito-borne illness that has become the leading cause of epidemic encephalitis in the country. The Centers for Disease...

In collaboration with . Visit us at: &  for more information. Professor Emeritus Lulu Bravo is the Executive Director of the Philippine Foundation for Vaccination and Pediatric Infectious Disease...

The fight against infectious diseases in Southeast Asia is increasingly tied to health literacy. Nine countries are focusing on improving public understanding of COVID-19 and other outbreaks by participating...

Researchers from several U.S. institutions have developed an mRNA vaccine that has proven effective in protecting mice against intestinal Clostridioides difficile bacterial infections. In their paper published...

In recent years, the focus on SARS-CoV-2 and mRNA-based vaccines has overshadowed work on other infectious diseases and vaccine approaches. However, attention is now shifting, as experts from three vaccine...

Seventy-Ninth Edition of the Global Health Cast presented by Prof. Schmitt and Dr. Sanicas.

Download the PDF here

Antimicrobial resistance (AMR) poses a significant and urgent global public health threat, requiring immediate and sustained political attention. This growing challenge demands the use of all available...

As mpox cases spread across Europe, experts suggest this rise may be linked to declining immunity against its far more lethal relative, smallpox. In 1970, doctors in the Democratic Republic of Congo...

UW Medicine will lead one of the seven new centers in a network funded by the National Institute of Allergy and Infectious Diseases (NIAID) to prepare against a variety of dangerous pathogens. NIAID is part of...

For decades, mpox, a zoonotic disease caused by the monkeypox virus, has posed a persistent public health challenge in parts of Central and West Africa, where it is endemic. Despite its impact, the disease...

One of the first moves a general makes before a battle is to scout the terrain. Without understanding the battlefield, tactics, strategy, and supply lines mean little. Similarly, when doctors, researchers, and...

A recent survey commissioned by the Abbott Pandemic Defense Coalition reveals that 61% of infectious disease professionals believe mosquito-borne pathogens pose the greatest threat as climate change...

Seventy-Eighth Edition of the Global Health Cast presented by Prof. Schmitt and Dr. Sanicas.

 
Download the PDF here

Scientists have made a groundbreaking discovery, uncovering how plants prevent viruses from being passed to their offspring. This finding not only holds promise for developing healthier crops but may also...

Targeting vaccination programs for respiratory syncytial virus (RSV) to older adults with underlying health conditions is a cost-effective way to reduce disease, according to a new modelling study. RSV...

Researchers at the Institut Pasteur in France have developed artificial “lymphoid organ-chips” that recreate much of the human immune system’s response to booster vaccines. The technology, described in an...

With flu season just around the corner and COVID-19 cases on the rise, a new nationwide survey from The Ohio State University Wexner Medical Center reveals hesitancy around vaccines this fall. The new data...

Seventy-Seventh Edition of the Global Health Cast presented by Prof. Schmitt and Dr. Sanicas.

Download the PDF here

The good news is, the risk of developing Long COVID has dropped significantly since the start of the pandemic—and, according to a new study, we have COVID-19 vaccines to thank for much of this decline. The bad...

UNICEF has announced the issuance of an emergency tender to procure mpox vaccines, aiming to curb the ongoing outbreak that has been declared a public health emergency by both the Africa Centres for Disease...

Seventy-Sixth Edition of the Global Health Cast presented by Prof. Schmitt and Dr. Sanicas.

Download the PDF here

Researchers at the University of Liverpool and the University of Oxford have for the first time been able to estimate the current burden of Lassa fever, project the impacts of a Lassa fever vaccination...

A team led by Jose Onuchic at Rice University and Paul Whitford at Northeastern University, both researchers at the National Science Foundation Physics Frontiers Center at the Center for Theoretical Biological...

Seventy-fifth Edition of the Global Health Cast presented by Prof. Schmitt and Dr. Sanicas.

Download the PDF here

This strain of the virus is known to be more severe, but it’s behaving differently from its usual patterns. The World Health Organization’s decision to declare mpox a global public health emergency for the...

The World Health Organization has declared mpox a public health emergency of international concern – a new variant of the virus has caused an outbreak in Central and West Africa and spread to Sweden The World...

A study published in Eurosurveillance analysing 5.5 million cases of infectious diseases in the European Union/European Economic Area (EU/EEA) over 10 years has found important differences in the relative...

Scientists react to the WHO declaring Mpox a Public Health Emergency of International Concern. Dr Brian Ferguson, Associate Professor of Immunology, University of Cambridge, said: “The WHO has declared a PHEIC...

Seventy-fourth Edition of the Global Health Cast presented by Prof. Schmitt and Dr. Sanicas.

Download the PDF here